Tyriakidis Konstantinos, Stadlmann Sylvia, Pederiva Stefanie
Department of Medical Oncology, Cantonal Hospital Baden, Baden, Switzerland.
Institute of Pathology, Cantonal Hospital Baden, Baden, Switzerland.
Case Rep Oncol. 2021 Mar 8;14(1):365-370. doi: 10.1159/000514048. eCollection 2021 Jan-Apr.
Small-cell carcinoma of the pancreas (PSCC) is a highly aggressive neoplasia with a dismal prognosis. It is extremely rare, with only a few cases reported in the literature. There is a paucity of clinical data to guide management and since the disease is mainly diagnosed at an advanced stage standard treatment consists of chemotherapy based upon treatment protocols used for small-cell lung cancer. We report the case of a female diagnosed with PSCC who achieved complete clinical remission after treatment with carboplatin and etoposide. During a 3-year follow-up the patient developed a gallbladder adenocarcinoma that was treated by surgical resection but relapsed within 20 months with widespread hematogenous metastasis.
胰腺小细胞癌(PSCC)是一种侵袭性很强的肿瘤,预后很差。它极为罕见,文献中仅报道了少数病例。缺乏指导治疗的临床数据,且由于该疾病主要在晚期被诊断出来,标准治疗方案是基于用于小细胞肺癌的治疗方案进行化疗。我们报告了一例被诊断为PSCC的女性患者,其在接受卡铂和依托泊苷治疗后实现了完全临床缓解。在3年的随访期间,该患者发生了胆囊腺癌,通过手术切除进行了治疗,但在20个月内复发并出现广泛的血行转移。